Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Genetics Generation Advancement Corp. (4160) Financial Statements

Genetics Generation Advancement Corp. Financial Overview

Genetics Generation Advancement Corp.'s market cap is currently NT$1.00B. The company's EPS TTM is NT$0.68; its P/E ratio is 52.78; and it has a dividend yield of 4.93%. Genetics Generation Advancement Corp. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 603.11MNT$ 661.86MNT$ 592.50MNT$ 547.81MNT$ 519.51M
Gross ProfitNT$ 250.44MNT$ 280.01MNT$ 236.83MNT$ 226.44MNT$ 195.49M
Operating IncomeNT$ 11.82MNT$ 49.53MNT$ 18.58MNT$ 34.01MNT$ 10.26M
EBITDANT$ 37.22MNT$ 85.95MNT$ 50.60MNT$ 44.01MNT$ 20.48M
Net IncomeNT$ 21.46MNT$ 54.70MNT$ 28.57MNT$ 25.73MNT$ 7.84M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 408.95MNT$ 414.48MNT$ 315.61MNT$ 259.24MNT$ 200.57M
Total AssetsNT$ 806.05MNT$ 724.30MNT$ 595.05MNT$ 455.66MNT$ 424.76M
Total DebtNT$ 80.08MNT$ 41.19MNT$ 49.30MNT$ 3.33MNT$ 2.42M
Net DebtNT$ 14.41MNT$ -87.81MNT$ -79.18MNT$ -54.12MNT$ -82.86M
Total LiabilitiesNT$ 204.05MNT$ 170.81MNT$ 164.91MNT$ 108.20MNT$ 106.06M
Stockholders' EquityNT$ 601.55MNT$ 553.13MNT$ 429.94MNT$ 347.46MNT$ 318.92M
Cash Flow
Free Cash FlowNT$ -49.64MNT$ 55.61MNT$ 61.74MNT$ 43.67MNT$ -3.11M
Operating Cash FlowNT$ -18.33MNT$ 81.62MNT$ 66.86MNT$ 51.81MNT$ 7.32M
Investing Cash FlowNT$ -26.34MNT$ -60.42MNT$ -7.80MNT$ -71.52MNT$ 10.19M
Financing Cash FlowNT$ -18.51MNT$ -20.96MNT$ 12.25MNT$ -7.80MNT$ -751.00K

Currency in TWD

Genetics Generation Advancement Corp. Earnings and Revenue History

-400M0400M800M-5 %0 %5 %10 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Genetics Generation Advancement Corp. Liabilities to Assets

0300M600M900M21 %24 %27 %30 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Genetics Generation Advancement Corp. Cash Flow

-100M-50M050M100M2019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Genetics Generation Advancement Corp. Forecast EPS vs Actual EPS

-0.100.10.20.30.40.5Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26EPS EstimateBeatMiss
Earnings >